Prothea Technologies
PrivateLast Round
Series A
Apr 9, 2024
Total Funding Raised
$13M
Momentum Score
25 /100
Company Overview
Prothea Technologies is a medical technology company that is developing a platform for lung cancer biopsy and treatment in a single hospital visit.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Usage-Based SaaS, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prothea Technologies Comps
Public and private peers based on sector, stage, and business model.
Prothea Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 9, 2024 |
Key People
Founding team and executive leadership
Prothea Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korys | Series A |
| Old College Capital | Series A |
| NRW.Bank | Series A |
| Earlybird Venture Capital | Series A |
| Mérieux Equity Partners | Series A |
Prothea Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Prothea Technologies's valuation, stock price, and market status.
